Cited 0 times in
Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 윤선옥 | - |
dc.contributor.author | 이청 | - |
dc.date.accessioned | 2023-08-23T00:14:57Z | - |
dc.date.available | 2023-08-23T00:14:57Z | - |
dc.date.issued | 2023-09 | - |
dc.identifier.issn | 1368-8375 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/196192 | - |
dc.description.abstract | Objectives: We aimed to investigate genetic alterations in oral tongue squamous cell carcinoma (OTSCC) based on age and the clinical significance of these alterations in young OTSCC patients. Materials and Methods: We detected genetic alterations in 44 cases of advanced OTSCC through next-generation sequencing and analyzed and compared patients either younger or older than 45 years. Further analysis was conducted on a validation group of 96 OTSCC patients aged ≤ 45 years to examine the clinical and prognostic associations of TERT promoter (TERTp) mutations. Results: TP53 mutation was the most common genetic alteration in advanced OTSCC (88.6%), followed by TERTp mutation (59.1%), CDKN2A mutation (31.8%), FAT1 mutation (9.1%), NOTCH1 mutation (9.1%), EGFR amplification (18.2%), and CDKN2A homozygous deletion (4.5%). TERTp mutation was the only genetic alteration significantly enriched in young patients (81.3% in young versus 46.4% in older; P < 0.024). Within the validation group of young patients, TERTp mutation was identified in 30 cases (30/96, 31.3%) and tended to be related to both smoking and alcohol consumption (P = 0.072), higher stage (P = 0.002), more frequent perineural invasion (P = 0.094), and worse overall survival (P = 0.012) than wild type. Conclusion: Our findings suggest that TERTp mutation is more frequent in young patients with advanced OTSCC and is associated with worse clinical outcomes. Therefore, TERTp mutation may serve as a prognostic biomarker for OTSCC in young patients. The findings of this study may help in developing personalized treatment strategies for OTSCC based on age and genetic alterations. © 2023 The Authors | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | ORAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Carcinoma, Squamous Cell* / pathology | - |
dc.subject.MESH | Head and Neck Neoplasms* / genetics | - |
dc.subject.MESH | Homozygote | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Sequence Deletion | - |
dc.subject.MESH | Squamous Cell Carcinoma of Head and Neck / genetics | - |
dc.subject.MESH | Tongue Neoplasms* / pathology | - |
dc.title | Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pathology (병리학교실) | - |
dc.contributor.googleauthor | Sehui Kim | - |
dc.contributor.googleauthor | Chung Lee | - |
dc.contributor.googleauthor | Hyangmi Kim | - |
dc.contributor.googleauthor | Sun Och Yoon | - |
dc.identifier.doi | 10.1016/j.oraloncology.2023.106466 | - |
dc.contributor.localId | A02566 | - |
dc.relation.journalcode | J02440 | - |
dc.identifier.eissn | 1879-0593 | - |
dc.identifier.pmid | 37393663 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1368837523001628 | - |
dc.subject.keyword | Genetics | - |
dc.subject.keyword | Head and neck | - |
dc.subject.keyword | Oral cavity | - |
dc.subject.keyword | Squamous cell carcinoma | - |
dc.subject.keyword | TERT | - |
dc.subject.keyword | Tongue | - |
dc.subject.keyword | Young age | - |
dc.contributor.alternativeName | Yoon, Sun Och | - |
dc.contributor.affiliatedAuthor | 윤선옥 | - |
dc.citation.volume | 144 | - |
dc.citation.startPage | 106466 | - |
dc.identifier.bibliographicCitation | ORAL ONCOLOGY, Vol.144 : 106466, 2023-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.